A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Active, not recruiting · NCT06292923 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 | 2026-07-02 | NCT06292923 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tiziana Life Sciences LTD | 5 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Cornell Weill Medical Center | New York | United States | 1 |
| Johns Hopkins | Baltimore | United States | 39 |
| Thomas Jefferson University Hospital | Philadelphia | United States | 271 |
| University of Buffalo | Buffalo | United States | 2 |
| University of Massachusetts | Worcester | United States | 16 |
| Yale | North Haven | United States | 1 |